Illumina, IDbyDNA partner for COVID-19 surveillance

By The Science Advisory Board staff writers

March 17, 2020 -- IDbyDNA and Illumina have partnered to bring next-generation sequencing (NGS) workflows to the global microbiology market to combat the COVID-19 pandemic. The companies will accelerate and improve testing for infectious diseases with NGS surveillance technology.

Under the terms of the agreement, the companies will co-market IDbyDNA's Explify platform for use with Illumina's NGS systems and library preparation. Together, the technologies will provide a streamlined workflow for infectious disease applications. In addition, IDbyDNA and Illumina will partner to codevelop research-use-only (RUO) workflows.

The partnership will enable broad distribution of NGS equipment and library prep, as well as high-fidelity NGS reagents and interpretation and reporting capabilities to laboratories and hospitals around the world.

The initial commercial RUO workflows derived from the partnership will focus on multiple infections, both routine and emerging public threats, for which pathogen identification and information regarding antimicrobial resistance markers can be improved with NGS techniques.

IDby DNA's Explify platform provides actionable insights that can be derived from NGS data. The companies believe that NGS-based testing in microbiology is the future of infectious disease testing and the combined technologies will provide the most comprehensive testing currently available.

Dante Labs offers free whole-genome sequencing services to scientists
Dante Labs, an Italy-based commercial genomics laboratory, announced it has started a program to support global scientific research on the novel coronavirus....
Institut Pasteur reveals how it sequenced the coronavirus
On January 30, the Institut Pasteur became the first European institution to sequence the novel coronavirus (2019-nCoV) since the outbreak began in December...
Enrichment NGS emerges as surveillance tool for coronavirus
As the coronavirus continues to grow as a global health concern, researchers urgently seek efficient methods to predict and mitigate emerging coronavirus...

Copyright © 2020 scienceboard.net


Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
Email
Conferences
2nd Annual Cell Therapy Bioprocessing Conference
June 25-26
Boston, Massachusetts United States
BioProcess International Europe
July 13-16
Amsterdam, Noord-Holland Netherlands
Bioprocess International West
August 10-13
Santa Clara, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter